4//SEC Filing
Lefebvre Eric 4
Accession 0001062993-23-001495
CIK 0001042074other
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 4:33 PM ET
Size
5.3 KB
Accession
0001062993-23-001495
Insider Transaction Report
Form 4
Lefebvre Eric
Director
Transactions
- Award
Stock Option (right to buy)
2023-01-25+25,000→ 25,000 totalExercise: $7.80Exp: 2033-01-24→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The option vests as to 1/12 of the underlying shares monthly from January 1, 2023.
Issuer
CymaBay Therapeutics, Inc.
CIK 0001042074
Entity typeother
Related Parties
1- filerCIK 0001614741
Filing Metadata
- Form type
- 4
- Filed
- Jan 26, 7:00 PM ET
- Accepted
- Jan 27, 4:33 PM ET
- Size
- 5.3 KB